Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer.

Ahmed GawishNurlan AbdulayevSouhir El-ArayedBurkard RöllichHans-Joachim OchelThomas B Brunner

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)

SBRT is a highly successful and safe way of treating patients with oligometastatic prostate cancer. Additional research is needed to examine 68Ga PSMA PET/CT to assess further for demarcation and follow-up.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
radiation therapy
positron emission tomography
computed tomography